Thermo Fisher Scientific Inc. (NYSE:TMO)

The financial performance over the analyzed five-year period is characterized by a persistent negative economic profit, indicating that the returns generated from operations have consistently fallen short of the company's cost of capital. While there are signs of operational recovery in the latter years, the expansion of the capital base has hindered the ability to achieve a positive economic value added.

Net Operating Profit After Taxes (NOPAT)

A fluctuating trend is observed in NOPAT, which declined from 7,514 million USD in 2021 to a low of 5,117 million USD in 2023. A subsequent recovery phase began in 2024, with figures rising to 6,467 million USD by 2025, although this remains below the 2021 baseline.

Cost of Capital

The cost of capital remained relatively stable throughout the period, fluctuating within a narrow range between 14.32% and 14.83%. This stability suggests a consistent risk profile and financing cost environment over the five-year span.

Invested Capital

Invested capital exhibited a general upward trajectory, increasing from 79,776 million USD in 2021 to 94,150 million USD in 2025. A brief contraction occurred in 2024, where capital decreased to 82,071 million USD, before a significant expansion in the final year.

Economic Profit

Economic profit remained negative for all five years, signifying value destruction. The deficit widened significantly from -3,946 million USD in 2021 to a peak loss of -7,459 million USD in 2023. Despite the recovery in NOPAT, the economic profit remained deeply negative, ending at -7,014 million USD in 2025.

The widening gap between operating returns and the cost of capital is primarily attributed to the increase in invested capital coinciding with a period of depressed NOPAT. The recovery in operating profit observed in 2024 and 2025 was insufficient to offset the capital charge associated with the expanded asset base, resulting in a sustained inability to generate positive economic value.

Net income attributable to Thermo Fisher Scientific Inc. and Net Operating Profit After Taxes (NOPAT) both demonstrate fluctuations over the five-year period. While net income shows a relatively stable pattern, NOPAT exhibits a more pronounced decline followed by recovery.

Net Income Trend

Net income attributable to Thermo Fisher Scientific Inc. decreased from US$7,725 million in 2021 to US$6,950 million in 2022. A further decrease was observed in 2023, reaching US$5,995 million. Subsequently, net income increased to US$6,335 million in 2024 and continued to rise to US$6,704 million in 2025, though it did not return to the 2021 level.

NOPAT Trend

NOPAT experienced a more significant decline than net income. Starting at US$7,514 million in 2021, it decreased to US$6,425 million in 2022. The decline accelerated in 2023, falling to US$5,117 million. A modest recovery occurred in 2024, with NOPAT reaching US$5,400 million. The most substantial increase within the observed period occurred between 2024 and 2025, with NOPAT rising to US$6,467 million. Despite this recovery, the 2025 NOPAT figure remains below the 2021 level.

Relationship between Net Income and NOPAT

The values for net income and NOPAT are closely aligned throughout the period, suggesting a limited impact from financing costs or non-operating items. The proportional changes in both metrics are similar, indicating that the core operating profitability is the primary driver of overall profitability. However, the magnitude of the NOPAT decline in 2023 was greater than that of net income, potentially indicating changes in the tax rate or other adjustments between net income and NOPAT.

The recovery in both net income and NOPAT in the later years of the period suggests a potential stabilization or improvement in the company’s operating performance. Further investigation would be required to determine the underlying causes of these fluctuations and the sustainability of the recent recovery.

The provision for income taxes and cash operating taxes exhibited distinct trends between 2021 and 2025. A significant decrease in the provision for income taxes is apparent over the period, while cash operating taxes demonstrate more fluctuation.

Provision for Income Taxes

The provision for income taxes decreased substantially from US$1,109 million in 2021 to US$284 million in 2023. A moderate increase was then observed in 2024, reaching US$657 million, followed by a further decrease to US$547 million in 2025. This represents an overall decline of approximately 50.7% from 2021 to 2025.

Cash Operating Taxes

Cash operating taxes remained relatively stable between 2021 and 2023, fluctuating around US$1,800 million. A notable increase occurred in 2024, with cash operating taxes rising to US$1,946 million. However, a considerable decrease was recorded in 2025, falling to US$1,290 million. The net change from 2021 to 2025 is a decrease of approximately 30.9%.

The divergence between the provision for income taxes and cash operating taxes suggests potential differences in temporary versus permanent tax differences. The substantial reduction in the provision for income taxes, coupled with the fluctuating cash operating taxes, warrants further investigation into the underlying factors driving these trends, such as changes in tax regulations, deferred tax asset realization, or shifts in the composition of taxable income.

Relationship between Provision and Cash Taxes

In 2021, cash operating taxes exceeded the provision for income taxes by US$757 million. This difference narrowed in 2022 to US$1,103 million and further decreased in 2023 to US$1,417 million. The gap widened again in 2024 to US$1,289 million before decreasing significantly in 2025 to US$743 million. This fluctuating difference highlights the impact of timing differences between reported income tax expense and actual cash tax payments.

The observed trends indicate a complex tax profile, and continued monitoring of these figures is recommended to assess potential impacts on future cash flows and overall financial performance.

The invested capital of the company demonstrates an overall increasing trend between 2021 and 2025, though with some fluctuation. Total reported debt & leases and total shareholders’ equity both contribute to this figure, and their individual movements influence the overall invested capital.

Invested Capital Trend

Invested capital increased from US$79,776 million in 2021 to US$82,814 million in 2022, representing a growth of approximately 3.8%. Further growth was observed in 2023, reaching US$85,573 million. A slight decrease occurred in 2024, with invested capital falling to US$82,071 million. However, a significant increase is noted in 2025, with invested capital reaching US$94,150 million.

Debt & Leases

Total reported debt & leases remained relatively stable between 2021 and 2023, fluctuating around US$36 billion. A decrease was observed in 2024, falling to US$32,775 million. This downward trend was reversed in 2025, with debt & leases increasing substantially to US$40,855 million.

Shareholders’ Equity

Total shareholders’ equity exhibited consistent growth throughout the period. It increased from US$40,793 million in 2021 to US$43,978 million in 2022, US$46,735 million in 2023, and US$49,584 million in 2024. This growth continued into 2025, reaching US$53,407 million. The consistent increase in shareholders’ equity contributes to the overall growth in invested capital.

The increase in invested capital in 2025 is primarily driven by a substantial rise in debt & leases, despite continued growth in shareholders’ equity. The dip in invested capital in 2024 is attributable to the decrease in debt & leases, partially offset by the continued growth in shareholders’ equity. These fluctuations suggest potential shifts in the company’s capital structure and financing strategies.

Analysis of the economic value added metrics reveals a consistent trend of value destruction over the period from 2021 to 2025. The organization has consistently reported negative economic profits, indicating that operating returns have been insufficient to cover the weighted average cost of the capital employed.

Economic Profit Trends

Economic profit experienced a significant decline between 2021 and 2023, moving from -3,946 million to a period low of -7,459 million. A slight recovery was observed in 2024, followed by a marginal dip to -7,014 million in 2025. The persistence of these negative values indicates that the business has not generated a return above its cost of capital for five consecutive years.

Invested Capital Fluctuations

Invested capital grew from 79,776 million in 2021 to 85,573 million by 2023. Following a temporary contraction to 82,071 million in 2024, there was a substantial increase to 94,150 million in 2025. This expansion of the capital base, particularly in the final year, has occurred while economic profits remained negative, suggesting that recent capital injections have not yet yielded positive economic value.

Economic Spread Ratio Performance

The economic spread ratio remained negative throughout the reporting period, reflecting a return on invested capital that is consistently lower than the cost of capital. The spread widened from -4.95% in 2021 to its most negative point of -8.72% in 2023. Since 2023, a gradual trend of improvement has emerged, with the ratio narrowing to -8.25% in 2024 and -7.45% in 2025, indicating a slow convergence toward the cost of capital benchmark.

The analysis of economic value creation over the five-year period from 2021 to 2025 reveals a persistent failure to generate positive economic profit, indicating that the returns on invested capital have consistently remained below the required cost of capital.

Economic Profit Trends

A significant downward trajectory in economic profit was observed between 2021 and 2023, with the deficit widening from US$ 3,946 million to a peak loss of US$ 7,459 million. Although a slight recovery occurred in 2024, the economic profit returned to a deficit of US$ 7,014 million by 2025, confirming a sustained period of economic value destruction.

Revenue Correlation

Revenues exhibited volatility, increasing to US$ 44,915 million in 2022 before contracting slightly and stabilizing between US$ 42,857 million and US$ 44,556 million from 2023 through 2025. The lack of alignment between revenue growth and economic profit suggests that increased top-line performance has not been sufficient to offset the capital charges associated with the operation.

Economic Profit Margin Analysis

The economic profit margin deteriorated sharply from -10.06% in 2021 to its lowest point of -17.40% in 2023. A marginal stabilization is noted in the final two years, with the margin remaining nearly constant at approximately -15.7% in 2024 and 2025. This pattern indicates that the efficiency of generating economic value relative to revenue has remained impaired, failing to return to 2021 levels.